Remote History of Pneumothorax is NOT a Contraindication to PAP Therapy
A 40-year remote history of pneumothorax and past lung surgery is not an absolute contraindication to PAP therapy for OSA, though it warrants careful risk assessment and potentially modified initiation protocols.
Guideline Position on Contraindications
The most recent AASM clinical practice guideline 1 does not list remote pneumothorax or prior lung surgery as contraindications to PAP therapy. The guideline provides strong recommendations for PAP use in adults with OSA and excessive sleepiness, and conditional recommendations for those with impaired quality of life or comorbid hypertension. Notably, the guideline emphasizes that PAP therapy decisions should be based on objective OSA diagnosis and adequate follow-up, but does not exclude patients with remote pulmonary history.
The 2025 Chinese guidelines 2 similarly do not identify remote pneumothorax as a contraindication, recommending PAP as first-line therapy for moderate-to-severe OSA.
Risk Context from Case Reports
While PAP-related pneumothorax is documented in the literature, it remains exceedingly rare:
- Case reports describe pneumothorax occurring with PAP therapy primarily in patients with active underlying lung disease (COPD, bullous emphysema) 3, 4, 5
- One case involved a patient with COPD who developed pneumothorax after 4 months of APAP at 4-8 cmH₂O, but was successfully restarted on CPAP at 5 cmH₂O without recurrence 3
- Another case showed recurrent pneumothorax temporally associated with CPAP initiation in a patient with diaphragmatic hernia 5
Critical distinction: These cases involved patients with active structural lung disease or recent thoracic surgery—not remote 40-year-old histories.
Clinical Approach for This Patient
Risk Stratification
- Low risk: 40 years post-event with no intervening pulmonary issues, normal current lung function, no active bullous disease
- Moderate risk: Residual structural changes on imaging, reduced lung function, or history of recurrent pneumothoraces
- Higher risk: Active COPD, current bullous emphysema, or recent thoracic procedures
Recommended Protocol
Pre-initiation assessment:
- Obtain current chest imaging (chest X-ray minimum; CT if concerns exist)
- Perform pulmonary function testing to assess current lung status
- Review surgical records if available to understand the extent of prior intervention
Modified PAP initiation:
- Start with lower pressures (e.g., CPAP 5-6 cmH₂O or APAP with lower pressure range)
- Consider in-laboratory titration rather than home auto-titration for closer monitoring 1
- Educate patient on pneumothorax symptoms (sudden chest pain, severe dyspnea) and ensure immediate reporting
Enhanced follow-up:
- Early follow-up at 1 week (per guideline recommendations) 1
- Consider repeat chest imaging at 1-4 weeks if any respiratory symptoms develop
- Standard ongoing monitoring per AASM guidelines
Evidence Supporting PAP Use Despite Pulmonary History
The benefits of PAP therapy are substantial and well-documented:
- Reduces postoperative respiratory complications by 28% and unplanned ICU admissions by 56% in surgical patients 6
- Decreases emergency room visits, hospitalizations, and healthcare costs in patients with overlap syndrome (OSA + COPD) 7
The untreated OSA likely poses greater morbidity and mortality risk than the theoretical pneumothorax risk from a 40-year-old resolved event.
Key Caveats
- If the patient has active bullous lung disease or current COPD with emphysema, proceed with heightened caution and lower starting pressures
- Absolute contraindications to PAP (not applicable here) include: pneumothorax until treated, pneumomediastinum, or pneumocephalus
- The successful case of CPAP restart after PAP-induced pneumothorax 3 demonstrates that even recent pneumothorax is not necessarily a permanent contraindication
In summary: Proceed with PAP therapy using conservative pressure settings, enhanced monitoring, and patient education about warning signs. The 40-year interval makes this a historical finding rather than an active contraindication.